Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013
Diagnostics (Dx) Revenue	11.01B	10.88B	10.14B
Diagnostics (Dx) Revenue Growth	1.22%	7.22%	7.75%
Biopharma Laboratory Services (BLS) Revenue	3.16B	3.10B	2.92B
Biopharma Laboratory Services (BLS) Revenue Growth	1.91%	6.01%	5.35%
Revenue (Other)	-22.30M	-23.00M	-58.00M
Revenue (Total)	14.14B	13.95B	13.01B
Revenue (Total) Growth	1.38%	7.25%	6.97%

EBIT

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013
Diagnostics (Dx) Operating Earnings	1.81B	1.78B	1.61B
Diagnostics (Dx) Operating Earnings Growth	1.75%	10.81%	0.94%
Biopharma Laboratory Services (BLS) Operating Earnings	512.30M	498.50M	458.90M
Biopharma Laboratory Services (BLS) Operating Earnings Growth	2.77%	8.63%	15.80%
Operating Income (Other)	-883.90M	-893.70M	-978.50M
Operating Income (Total)	1.44B	1.38B	1.09B
Operating Income (Total) Growth	3.96%	27.42%	49.77%

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013
North America % Total Revenue	87.00%	87.00%
Europe % Total Revenue	9.00%	9.00%
Other Geography % Total Revenue	4.00%	4.00%
Organic Revenue Growth	4.40%	3.90%